Genetics of Appendix Cancer: The GAP Study

Status: Recruiting
Location: See location...
Intervention Type: Genetic, Other
Study Type: Observational
SUMMARY

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ GAP Social

• Known diagnosis of appendix cancer in the United States

• Mentally and physically able to consent and participate in the study

⁃ GAP Vanderbilt

• Known diagnosis of appendix cancer

• Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study

• Mentally and physically able to consent and participate in the study

⁃ GAP Parent

• Biological parents (mother and/or father) of individuals actively participating in the GAP Study

• Residing in the United States

• Mentally and physically able to consent and participate in the study

Locations
United States
Tennessee
Vanderbilt-Ingram Cancer Center
RECRUITING
Nashville
Contact Information
Primary
GAP Study Coordinator (Rebecca B.)
gapcancerstudy@vumc.org
615-936-8544
Time Frame
Start Date: 2022-11-11
Estimated Completion Date: 2034-11
Participants
Target number of participants: 700
Treatments
GAP Social
Individuals ages 18+ years with an appendix cancer diagnosis in the United States.
GAP Vanderbilt
Individuals ages 18+ years with an appendix cancer diagnosis seen at Vanderbilt.
GAP Parent
Biological parents of active GAP (Social and Vanderbilt) Study participants.
Related Therapeutic Areas
Sponsors
Leads: Andreana Holowatyj, PhD, MSCI

This content was sourced from clinicaltrials.gov